Historical record - last NADAC effective date: 2/17/2021
Product Information
BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1990 per EA under NDC 69097087903. Its NADAC has been published 233 times since Sep 14, 2016.
FDA first approved this application on Feb 9, 2016.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097087903
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/17/2021
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206674FDA Approved
2/9/2016
On Market Since
7/25/2016
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 233 times since Sep 14, 2016, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1990 per EA |
|---|---|
| All-time high | $0.3490 (Oct 12, 2016) |
| All-time low | $0.1990 (Feb 17, 2021) |
| Median price | $0.2424 |
| Average price | $0.2555 |
| Largest weekly change | -15.6% (Jul 17, 2019) |
| Weeks tracked | 233 |
| Tracking since | Sep 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-40.6%
Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bupropion Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bupropion Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Cipla USA Inc., is $0.1990 per EA (NDC 69097087903), effective Feb 24, 2021.
How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 40.6%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?
Since Sep 14, 2016, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1990 (Feb 17, 2021) to a high of $0.3490 (Oct 12, 2016), with a median of $0.2424 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUPROPION HCL SR 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUPROPION HCL SR 200 MG TABLET?
BUPROPION HCL SR 200 MG TABLET (NDC 69097087903) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.